Silence Therapeutics Plc (SLN)

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Wall Street Analysts. Silence Therapeutics plc (NASDAQ:SLN) is one of the most promising stocks on our list.

In this article, we will be taking a look at the 10 Most Promising Cancer Stocks According to Wall Street Analysts.

In this article, we look at 10 Small Cap Stocks with Potential to Rise 1000 Percent. Small-cap stocks have returned to the market’s risk conversation in 2026.

​This article will examine 20 takeover rumors that have prompted hedge funds to buy stocks. Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.

Silence Therapeutics plc (NASDAQ:SLN) Q4 2024 Earnings Call Transcript February 28, 2025 Gem Hopkins: Good morning and good afternoon, everyone. Thank you for joining us today.

In this piece, we will take a look at ten oversold global stocks to buy now.

In this article, we will take a look at the 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds.

Silence Therapeutics plc (NASDAQ:SLN) Q4 2023 Earnings Call Transcript March 13, 2024 Silence Therapeutics plc misses on earnings expectations. Reported EPS is $-0.47 EPS, expectations were $-0.25.

Silence Therapeutics plc (NASDAQ:SLN) Q4 2022 Earnings Call Transcript March 15, 2023 Operator: Good day and thank you for standing by.